Woman’s healthcare continues to play an increasingly important role in the growth and strength of the healthcare industry in the Middle East.
According to IMS, a leading healthcare market-intelligence consultancy, the women’s healthcare market exceeded $16.5bn worldwide in 2007 and this figure is poised to grow to $27.3bn in 2019.
Pfizer, the world’s largest research-based pharmaceutical company, are in Dubai during the opening day of the Obs-Gyne Exhibition & Congress, taking place at the show’s new location in the Dubai International Convention and Exhibition Centre from 14 to 16 February 2010, showcasing their latest women’s health line including leading products such as Dostinex, Detrusitol, Dalacin and Diflucan.
“Healthcare events such as the Obs-Gyne Exhibition & Congress are important for Pfizer in many ways,” said Mr. Rajkumar B. Nair, Product Manager – Established Products, Gulf States & Emerging Markets, Pfizer. “On an international scale we believe in partnering with gynaecological societies to upgrade their skills and knowledge which can be done through CME (Continuing Medical Education) partnership and, also, through participation at these types of exhibitions and scientific congresses.”
“Product exposure is a key factor behind out decision to exhibit at the Obs-Gyne Exhibition & Congress as we have exposure to a large number of women’s healthcare professionals but we are also keen to show support for the international speakers attending the congress with our continued presence and support at the event.”
Mr Nair is confident in the continued growth of the healthcare market in the region. He explains:
“The Middle East healthcare industry continues to grow with infectious diseases and cardiovascular products the fastest growing. Currently, the Gulf States are applying their healthcare infrastructure according to market needs rather than over-supply and excess, as is the case in many other countries. International institutions such as the Cleveland Clinic and Johns Hopkins Medical are partnering with local health authorities and hospitals which in turn is adding value for patients to be treated locally rather than have to travel abroad for treatment. The future for the UAE looks bright with a new teaching hospital planned for the Dubai Healthcare City under the management of Harvard Medical School as well as the planned completion of the Saudi German Hospital currently under construction in Al Barsha, Dubai.”
For the first time, during the Middle East Obs-Gyne Congress, there is a conference dedicated to midwifery on the 15 and 16 February, 2010. The Middle East Midwifery Conference will focus on antenatal, intrapartum and postnatal care as well as obstetric emergencies and midwifery education.
A specialised Middle East Breast Cancer Conference accredited by the Cleveland Clinic and under the medical supervision of Johns Hopkins Medicine in Baltimore, Maryland is also running on Days 1 and 2 of the event.
The Obs-Gyne Exhibition & Congress will run from 14 to 16 February 2010 at the Dubai International Convention and Exhibition Centre.